Blogs

Property Lines

Welcome to Property Lines, Indy's favorite source for neighborhood real estate news. Your host, IBJ real estate beat reporter Scott Olson, can be reached at solson@ibj.com. Read More

New plan emerges for Broad Ripple Legion site

A local developer no longer is pursuing plans to build a five-story office building on the property. A small real estate brokerage firm in the neighborhood now hopes to renovate the space and move its office there.
Read More
More Property Lines Property Lines RSS FeedSubscribe

Lou Harry's A&E

Yes, you've found Lou Harry's A&E, IBJ's home for opinion, debate and discussion on arts and entertainment matters in Indy and beyond.  Thanks for stopping by.

Read More
More Lou Harry's A&E Lou Harry's A&E RSS FeedSubscribe

The Score

Welcome to The Score, your place for hard-hitting sports business news, fast-breaking updates and fuel-injected debate.  Buckle up.  I'm your host, Anthony Schoettle, IBJ sports reporter.

Read More
More The Score The Score RSS FeedSubscribe

North of 96th

Welcome to North of 96th, your source for business news from Carmel, Fishers, Noblesville, Westfield and Zionsville. Your host, Lindsey Erdody, can be reached at lerdody@ibj.com.

Read More
More North of 96th North of 96th RSS FeedSubscribe

The Dose

Welcome to The Dose, which tackles the finances behind local health care and life sciences and points to the most interesting national analysis. Your host is J.K. Wall.

Read More

Lilly expands R&D outside Indy—again

State and city leaders spend millions each year to entice companies to move here and add jobs here. But for the second time in three months, Eli Lilly and Co. has shown that the biggest attraction to a company is talented workers.
Read More

Lilly faces moment of truth this week

The Indianapolis-based drugmaker on Wednesday will release new data from patients taking its Alzheimer’s drug that could show whether the drug has slowed the progression of their disease. That will show investors whether the 45 percent rise in Lilly’s stock price over the past year is justified.
Read More
More The Dose The Dose RSS FeedSubscribe